Want to see TSE:PHRM full AI Analyst Report?
PharmaTher Holdings Ltd (PHRM) Stock Statistics & Valuation Metrics
Total Valuation
PharmaTher Holdings Ltd has a market cap or net worth of CAD 5.01M. The enterprise value is CAD 4.24M.
- Market Cap
- CAD 5.01M
- Enterprise Value
- CAD 4.24M
Share Statistics
PharmaTher Holdings Ltd has 91,019,066 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 91,019,066
- Owned by Insiders
- 0.44%
- Owned by Institutions
- <0.01%
Financial Efficiency
PharmaTher Holdings Ltd’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -137.98%.
- Return on Equity (ROE)
- -1.00
- Return on Assets (ROA)
- -0.54
- Return on Invested Capital (ROIC)
- -137.98%
- Return on Capital Employed (ROCE)
- -1.38
- Revenue Per Employee
- 0
- Profits Per Employee
- -76.30K
- Employee Count
- 8
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of PharmaTher Holdings Ltd is -13.10. PharmaTher Holdings Ltd’s PEG ratio is -0.08.
- PE Ratio
- -13.10
- PS Ratio
- 0.00
- PB Ratio
- 12.76
- Price to FCF
- -10.32
- Price to Operating Cash Flow
- -10.32
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, PharmaTher Holdings Ltd had revenue of 0 and earned -610.44K in profits. Earnings per share was -0.01.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -845.95K
- Pretax Income
- -610.44K
- Net Income
- -610.44K
- EBITDA
- -845.95K
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -485.01K and capital expenditures 3, giving a free cash flow of -485.00K billion.
- Operating Cash Flow
- -485.01K
- Free Cash Flow
- -485.00K
- Free Cash Flow per Share
- -0.01
Dividends & Yields
PharmaTher Holdings Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.69%
- Earnings Yield
- -7.83%
Stock Price Statistics
- Beta
- -0.26
- 52-Week Price Change
- -52.17%
- 50-Day Moving Average
- 0.06
- 200-Day Moving Average
- 0.07
- Relative Strength Index (RSI)
- 50.61
- Average Volume (3m)
- 64.28K
Important Dates
PharmaTher Holdings Ltd upcoming earnings date is Jan 22, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Jan 22, 2027
- Ex-Dividend Date
- ―
Financial Position
PharmaTher Holdings Ltd as a current ratio of 1.83, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.83
- Quick Ratio
- 1.83
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.81
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, PharmaTher Holdings Ltd has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
PharmaTher Holdings Ltd EV to EBITDA ratio is -7.79, with an EV/FCF ratio of -9.08.
- EV to Sales
- 0.00
- EV to EBITDA
- -7.79
- EV to Free Cash Flow
- -9.08
- EV to Operating Cash Flow
- -9.08
Balance Sheet
PharmaTher Holdings Ltd has CAD 921.54K in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of CAD 921.54K billion.
- Cash & Marketable Securities
- CAD 921.54K
- Total Debt
- CAD 0.00
- Net Cash
- CAD 921.54K
- Net Cash Per Share
- CAD 0.01
- Tangible Book Value Per Share
- CAD 0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for PharmaTher Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 75.84%
Scores
- Smart Score
- ―
- AI Score
- 50
